DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study Evaluating Pantoprazole in Children With GERD

Information source: Wyeth
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gastroesophageal Reflux

Intervention: pantoprazole for approximately 9 weeks. (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth

Summary

The purpose of this study is to characterize the PK profile, safety and tolerability of single and multiple doses of pantoprazole in children aged 1 through 11 years with endoscopically proven GERD.

Clinical Details

Official title: A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years With Endoscopically Proven GERD.

Study design: Treatment, Randomized, Open Label, Dose Comparison, Single Group Assignment, Pharmacokinetics Study

Primary outcome: Characterization of the PK profile of single and multiple doses of pantoprazole.

Secondary outcome: Assessment of safety and tolerability of pantoprazole and assessment of growth parameters

Eligibility

Minimum age: 1 Year. Maximum age: 11 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Endoscopically proven GERD diagnosed within 6 months before study entry.

- Weight must be equal to or over 8. 3 kg; for subjects 6 years or greater, weight must

be equal to or under 25 kg

Exclusion Criteria:

- History of GI disorders, ie, unrepaired tracheal esophageal fistula, GI malabsorption,

Eosinophilic esophagitis

- Subjects 6-11 years old unable to swallow tablets

Locations and Contacts

Little Rock, Arkansas 72205, United States

San Diego, California 92103, United States

Orange, California 92868, United States

Washington, District of Columbia 20010, United States

Gainesville, Florida 32610, United States

Miami, Florida 33101, United States

Pensacola, Florida 32504, United States

Park Ridge, Illinois 60068, United States

Indianapolis, Indiana 46202, United States

Louisville, Kentucky 40202, United States

Brockton, Massachusetts 02302, United States

Boston, Massachusetts 02115, United States

Boston, Massachusetts 02114, United States

Detroit, Michigan 48201, United States

Flint, Michigan 48503, United States

Jackson, Mississippi 39216, United States

Kansas City, Missouri 64108, United States

New York, New York 10032, United States

Cincinnati, Ohio 45229, United States

Memphis, Tennessee 38105, United States

Temple, Texas 76508, United States

Salt Lake City, Utah 84108, United States

Milwaukee, Wisconsin 53226, United States

Additional Information

Starting date: August 2005
Ending date: November 2007
Last updated: December 18, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009